PDCD1 and melanoma: In conclusion, FMT and anti‐PD‐1 together successfully colonized the gut of responders and altered the microbiota composition, reprogramming the tumor microenvironment to counter anti‐PD‐1 resistance in the PD‐1 advanced melanoma subgroup.96